Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Insights

Understanding Multiple Sclerosis and the Treatment Advances

April 15th 2019

Non–Small Cell Lung Cancer Clinical Care

March 15th 2019

Emerging Agents for Myelofibrosis

December 28th 2018

Understanding Axial Spondyloarthritis

December 27th 2018

Patient Selection and Safety With TNF Inhibitors

November 26th 2018

Advances in the Treatment of Hyperhidrosis

August 2nd 2018

Current Treatment Regimens for Multiple Myeloma

July 25th 2018

Antiangiogenic Therapy: Appropriate Therapeutic Options and Sequencing in NSCLC

July 18th 2018

Personalized Selection of Upfront Therapy in CLL

July 11th 2018

PARP Inhibitors in the Management of Ovarian Cancer

November 28th 2017

Perspectives in the Management of Non-Small Cell Lung Cancer

May 12th 2017

Use of Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation

April 18th 2017

Clinical Progress and Coverage Policies in Immuno-Oncology

July 28th 2016

Updates in the Treatment of Pulmonary Arterial Hypertension

July 18th 2016

Updates in the Treatment of Chronic Lymphocytic Leukemia: Implications for Managed Care

July 18th 2016

Current Clinical Landscape and Managed Care Approach in Multiple Myeloma

July 6th 2016

Updates in the Management of Type 2 Diabetes Mellitus and Comorbid Dyslipidemia

May 27th 2016

The Evolution and Clinical Impact of Diagnostic Testing

October 29th 2015

Treatment for Patients With Thromboembolic Complications

July 24th 2015

Use of Oral Oncolytics In Palliative Care

June 10th 2015

The Clinical and Reimbursement Landscape of Immuno-Oncology

May 26th 2015

Innovative Payment Models in Oncology

May 13th 2015

Innovation and Role of Alternative Markers of Efficacy

January 23rd 2015

Assessing the Clinical Utility of Companion Diagnostics

January 16th 2015

New Standards of Care in the Management of Prostate Cancer

December 17th 2014

Defining the Value of Innovation in Oncology

November 6th 2014

Transitions of Care Challenges in Cardiology

April 30th 2014

Trending on AJMC

Retatrutide Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial

CVS Health Sued Over Alleged Scheme to Siphon 340B Drug Program Savings

Cost Plus Drugs Beats Commercial Insurance Co-Pays 80% of the Time

FNI Outperforms FIB-4 in Predicting 20-Year MASLD Mortality in T2D

Datopotamab Deruxtecan Wins First-Line FDA Approval for Immunotherapy-Ineligible Triple-Negative Breast Cancer